
Larimar Therapeutics president and CEO Carole Ben-Maimon acquires $49,953 in stock
Source link

Larimar Therapeutics president and CEO Carole Ben-Maimon acquires $49,953 in stock
Source link
Excepteur sint occaecat cupidatat non proident
Leave a comment